Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-06-16 Sale |
2023-06-16 4:00 pm |
Prometheus Biosciences Inc. | RXDX | Hendrix Martin Director |
2,071 | $0 | $0 | 0 (Direct) |
View |
| 2023-06-16 Sale |
2023-06-16 4:00 pm |
Prometheus Biosciences Inc. | RXDX | Laur James Director |
2,071 | $0 | $0 | 0 (Direct) |
View |
| 2023-06-16 Sale |
2023-06-16 4:00 pm |
Prometheus Biosciences Inc. | RXDX | Stenhouse Mark Chief Operating Officer |
26,754 | $0 | $0 | 0 (Indirect Direct) |
View |
| 2023-06-16 Sale |
2023-06-16 4:00 pm |
Prometheus Biosciences Inc. | RXDX | Szela Mary T Director |
2,071 | $0 | $0 | 0 (Direct) |
View |
| 2023-06-16 Sale |
2023-06-16 4:00 pm |
Prometheus Biosciences Inc. | RXDX | McKenna Mark C. Chairman, President and CEO |
178,098 | $0 | $0 | 0 (Direct) |
View |
| 2023-06-16 Sale |
2023-06-16 4:00 pm |
Prometheus Biosciences Inc. | RXDX | Swain Judith L Director |
2,071 | $0 | $0 | 0 (Direct) |
View |
| 2023-06-16 Sale |
2023-06-16 4:00 pm |
Prometheus Biosciences Inc. | RXDX | PAPA JOSEPH C Director |
17,278 | $0 | $0 | 0 (Indirect Direct) |
View |
| 2023-06-16 Sale |
2023-06-16 4:00 pm |
Prometheus Biosciences Inc. | RXDX | Hassan Fred Director |
2,123 | $0 | $0 | 0 (Direct) |
View |
| 2023-06-16 Sale |
2023-06-16 4:00 pm |
Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer |
87,973 | $0 | $0 | 0 (Direct) |
View |
| 2023-06-16 Sale |
2023-06-16 4:00 pm |
Prometheus Biosciences Inc. | RXDX | Adams Helen C. Director |
2,674 | $0 | $0 | 0 (Direct) |
View |
| 2023-04-05 Sale |
2023-04-07 9:02 pm |
Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer |
10,000 | $108.42 | $1,084,200 | 102,851 (Direct) |
View |
| 2023-03-15 Sale |
2023-03-17 9:02 pm |
Prometheus Biosciences Inc. | RXDX | McKenna Mark C. Chairman, President & CEO |
25,000 | $116.14 | $2,903,500 | 338,777 (Direct) |
View |
| 2023-03-06 Sale |
2023-03-08 9:33 pm |
Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer |
10,000 | $122.13 | $1,221,300 | 112,851 (Direct) |
View |
| 2023-03-08 Sale |
2023-03-08 9:30 pm |
Prometheus Biosciences Inc. | RXDX | Cedars Sinai Intellectual Property Co 10% Owner |
865,000 | $114.59 | $99,120,350 | 4,001,132 (Indirect) |
View |
| 2023-03-01 Sale |
2023-03-03 9:30 pm |
Prometheus Biosciences Inc. | RXDX | McKenna Mark C. Chairman, President & CEO |
11,320 | $125.14 | $1,416,563 | 1,029,214 (Direct) |
View |
| 2023-02-15 Sale |
2023-02-17 9:34 pm |
Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer |
5,000 | $119.38 | $596,900 | 122,851 (Direct) |
View |
| 2023-02-15 Sale |
2023-02-17 9:31 pm |
Prometheus Biosciences Inc. | RXDX | McKenna Mark C. Chairman, President & CEO |
63,680 | $120.82 | $7,693,618 | 1,363,547 (Direct) |
View |
| 2023-01-17 Sale |
2023-01-19 8:42 pm |
Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer |
5,000 | $119 | $595,000 | 127,851 (Direct) |
View |
| 2023-01-17 Sale |
2023-01-19 8:39 pm |
Prometheus Biosciences Inc. | RXDX | McKenna Mark C. Chairman, President & CEO |
25,000 | $118.99 | $2,974,750 | 388,777 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-02 Exercise |
2023-06-02 7:13 pm |
N/A N/A |
Prometheus Biosciences Inc. | RXDX | McKenna Mark C. Chairman, President & CEO |
122,528 | $2.9 | 471,882 (Direct) |
View |
| 2023-06-02 Exercise |
2023-06-02 7:13 pm |
N/A 2029-11-06 |
Prometheus Biosciences Inc. | RXDX | McKenna Mark C. Chairman, President & CEO |
122,531 | $0 | 471,882 (Direct) |
View |
| 2023-06-02 Exercise |
2023-06-02 7:13 pm |
N/A N/A |
Prometheus Biosciences Inc. | RXDX | McKenna Mark C. Chairman, President & CEO |
3 | $1.7 | 471,882 (Direct) |
View |
| 2023-06-02 Exercise |
2023-06-02 7:03 pm |
N/A 2030-08-11 |
Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer |
78,162 | $0 | 140,811 (Direct) |
View |
| 2023-06-02 Exercise |
2023-06-02 7:03 pm |
N/A N/A |
Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer |
78,162 | $3.1 | 140,811 (Direct) |
View |
| 2023-06-01 Other |
2023-06-02 6:57 pm |
N/A N/A |
Prometheus Biosciences Inc. | RXDX | Stenhouse Mark Chief Operating Officer |
14,000 | $0 | 54,708 (Direct) |
View |
| 2023-06-02 Other |
2023-06-02 6:43 pm |
N/A N/A |
Prometheus Biosciences Inc. | RXDX | PAPA JOSEPH C Director |
10,000 | $0 | 37,278 (Direct) |
View |
| 2023-05-19 Option Award |
2023-05-19 5:47 pm |
N/A N/A |
Prometheus Biosciences Inc. | RXDX | Szela Mary T Director |
2,071 | $0 | 2,071 (Direct) |
View |
| 2023-05-19 Option Award |
2023-05-19 5:45 pm |
N/A N/A |
Prometheus Biosciences Inc. | RXDX | Swain Judith L Director |
2,071 | $0 | 2,071 (Direct) |
View |
| 2023-05-19 Option Award |
2023-05-19 5:44 pm |
N/A N/A |
Prometheus Biosciences Inc. | RXDX | PAPA JOSEPH C Director |
2,278 | $0 | 17,278 (Direct) |
View |
| 2023-05-19 Option Award |
2023-05-19 5:42 pm |
N/A N/A |
Prometheus Biosciences Inc. | RXDX | Laur James Director |
2,071 | $0 | 2,071 (Direct) |
View |
| 2023-05-19 Option Award |
2023-05-19 5:41 pm |
N/A N/A |
Prometheus Biosciences Inc. | RXDX | Hendrix Martin Director |
2,071 | $0 | 2,071 (Direct) |
View |
| 2023-05-19 Option Award |
2023-05-19 5:39 pm |
N/A N/A |
Prometheus Biosciences Inc. | RXDX | Hassan Fred Director |
2,123 | $0 | 2,123 (Direct) |
View |
| 2023-05-19 Option Award |
2023-05-19 5:38 pm |
N/A N/A |
Prometheus Biosciences Inc. | RXDX | Adams Helen C. Director |
2,174 | $0 | 2,674 (Direct) |
View |
| 2023-04-05 Exercise |
2023-04-07 9:02 pm |
N/A 2030-12-17 |
Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer |
10,000 | $0 | 102,851 (Direct) |
View |
| 2023-04-05 Exercise |
2023-04-07 9:02 pm |
N/A N/A |
Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer |
10,000 | $3.7 | 102,851 (Direct) |
View |
| 2023-03-15 Exercise |
2023-03-17 9:02 pm |
N/A N/A |
Prometheus Biosciences Inc. | RXDX | McKenna Mark C. Chairman, President & CEO |
25,000 | $2.9 | 338,777 (Direct) |
View |
| 2023-03-15 Exercise |
2023-03-17 9:02 pm |
N/A 2029-11-06 |
Prometheus Biosciences Inc. | RXDX | McKenna Mark C. Chairman, President & CEO |
25,000 | $0 | 338,777 (Direct) |
View |
| 2023-03-06 Exercise |
2023-03-08 9:33 pm |
N/A 2030-12-17 |
Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer |
10,000 | $0 | 112,851 (Direct) |
View |
| 2023-03-06 Exercise |
2023-03-08 9:33 pm |
N/A N/A |
Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer |
10,000 | $3.7 | 112,851 (Direct) |
View |
| 2023-03-01 Exercise |
2023-03-03 9:30 pm |
N/A 2030-12-17 |
Prometheus Biosciences Inc. | RXDX | McKenna Mark C. Chairman, President & CEO |
11,320 | $0 | 1,029,214 (Direct) |
View |
| 2023-03-01 Exercise |
2023-03-03 9:30 pm |
N/A N/A |
Prometheus Biosciences Inc. | RXDX | McKenna Mark C. Chairman, President & CEO |
11,320 | $3.7 | 1,029,214 (Direct) |
View |
| 2023-02-15 Exercise |
2023-02-17 9:34 pm |
N/A 2030-12-17 |
Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer |
5,000 | $0 | 122,851 (Direct) |
View |
| 2023-02-15 Exercise |
2023-02-17 9:34 pm |
N/A N/A |
Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer |
5,000 | $3.7 | 122,851 (Direct) |
View |
| 2023-02-15 Exercise |
2023-02-17 9:31 pm |
N/A N/A |
Prometheus Biosciences Inc. | RXDX | McKenna Mark C. Chairman, President & CEO |
25,000 | $2.9 | 1,363,547 (Direct) |
View |
| 2023-02-15 Exercise |
2023-02-17 9:31 pm |
N/A 2029-11-06 |
Prometheus Biosciences Inc. | RXDX | McKenna Mark C. Chairman, President & CEO |
63,680 | $0 | 1,363,547 (Direct) |
View |
| 2023-02-16 Exercise |
2023-02-17 9:31 pm |
N/A N/A |
Prometheus Biosciences Inc. | RXDX | McKenna Mark C. Chairman, President & CEO |
38,680 | $3.7 | 1,363,547 (Direct) |
View |
| 2023-01-17 Exercise |
2023-01-19 8:42 pm |
N/A 2030-12-17 |
Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer |
5,000 | $0 | 127,851 (Direct) |
View |
| 2023-01-17 Exercise |
2023-01-19 8:42 pm |
N/A N/A |
Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer |
5,000 | $3.7 | 127,851 (Direct) |
View |
| 2023-01-17 Exercise |
2023-01-19 8:39 pm |
N/A N/A |
Prometheus Biosciences Inc. | RXDX | McKenna Mark C. Chairman, President & CEO |
25,000 | $2.9 | 388,777 (Direct) |
View |
| 2023-01-17 Exercise |
2023-01-19 8:39 pm |
N/A 2029-11-06 |
Prometheus Biosciences Inc. | RXDX | McKenna Mark C. Chairman, President & CEO |
25,000 | $0 | 388,777 (Direct) |
View |
| 2022-12-16 Option Award |
2022-12-20 8:19 pm |
N/A 2032-12-15 |
Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer |
12,920 | $0 | 12,920 (Direct) |
View |
| 2022-12-09 Option Award |
2022-12-13 8:38 pm |
N/A 2032-12-08 |
Prometheus Biosciences Inc. | RXDX | Stenhouse Mark Chief Operating Officer |
43,896 | $0 | 60,527 (Direct) |
View |
| 2022-12-09 Option Award |
2022-12-13 8:35 pm |
N/A 2032-12-08 |
Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer |
43,896 | $0 | 43,896 (Direct) |
View |
| 2022-12-09 Option Award |
2022-12-13 8:32 pm |
N/A 2032-12-08 |
Prometheus Biosciences Inc. | RXDX | McKenna Mark C. Chairman, President & CEO |
166,043 | $0 | 184,074 (Direct) |
View |
| 2022-05-19 Option Award |
2022-05-20 7:30 pm |
N/A 2032-05-18 |
Prometheus Biosciences Inc. | RXDX | Szela Mary T Director |
20,500 | $0 | 20,500 (Direct) |
View |
| 2022-05-19 Option Award |
2022-05-20 7:28 pm |
N/A 2032-05-18 |
Prometheus Biosciences Inc. | RXDX | Swain Judith L Director |
20,500 | $0 | 20,500 (Direct) |
View |
| 2022-05-19 Option Award |
2022-05-20 7:26 pm |
N/A 2032-05-18 |
Prometheus Biosciences Inc. | RXDX | PAPA JOSEPH C Director |
22,551 | $0 | 22,551 (Direct) |
View |
| 2022-05-19 Option Award |
2022-05-20 7:24 pm |
N/A 2032-05-18 |
Prometheus Biosciences Inc. | RXDX | Laur James Director |
20,500 | $0 | 20,500 (Direct) |
View |
| 2022-05-19 Option Award |
2022-05-20 7:22 pm |
N/A 2032-05-18 |
Prometheus Biosciences Inc. | RXDX | Hendrix Martin Director |
20,500 | $0 | 20,500 (Direct) |
View |
| 2022-05-19 Option Award |
2022-05-20 7:20 pm |
N/A 2032-05-18 |
Prometheus Biosciences Inc. | RXDX | Hassan Fred Director |
21,013 | $0 | 21,013 (Direct) |
View |